Premier Alternatives

Ablative Solutions

Wakefield, MA · Founded 2011 · Privately Held (backing)

Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. Ablative Solutions is based in Wakefield, MA and was founded in 2011. Its last reported valuation was $140 million in Jun 2022. It has raised $215 million across 4 recorded rounds; the latest was a $10.4 million early-stage round in Nov 2025.

Last reported valuation
$140.0M
Oct 2026
Priced at
—
Total raised
$214.6M
Last round
Early Stage VC
Nov 2025

Ablative Solutions key facts

as of Oct 2026
  • Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension.
  • Ablative Solutions is valued at approximately $140.0M as of Oct 2026 (last reported valuation).
  • It has raised $214.6M across 4 recorded rounds; the latest was Early Stage VC ($10.4M) in Nov 2025.
  • Notable investors include Invus Opportunities, Gilde Healthcare, BioStar Capital, CKM Capital, Charter Private Capital Management — 11 tracked in total.
  • Ablative Solutions has filed 3 Form Ds with the SEC since 2021, most recently Dec 2024 ($37.2M sold to 88 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$140.0M

Ablative Solutions's last reported valuation, Jun 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Ablative Solutions with a free account
  • ·The complete investor list: 11 names
  • ·Watch Ablative Solutions: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ablative Solutions funding rounds

4 rounds
Nov 2025Early Stage VC$10.4MSEC filing▮
Dec 2024Early Stage VC$37.2MSEC filing▮
Mar 2023Early Stage VC$13.0MSEC filing▮
Dec 2018Later Stage VC$54.5MSEC filing▮
Full funding history →

Ablative Solutions valuation

Ablative Solutions's last reported valuation was $140 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Ablative Solutions raised?

Ablative Solutions has raised $215 million across 4 recorded rounds since 2018. The largest was a $54.5 million later-stage round in Dec 2018; the most recent was a $10.4 million early-stage round in Nov 2025.

Ablative Solutions has filed 3 Form Ds with the SEC since 2021, most recently in Dec 2024 ($37.2 million sold to 88 investors).

Ablative Solutions investors

11 investors are on record for Ablative Solutions, including Invus Opportunities, Gilde Healthcare, BioStar Capital and CKM Capital. The early-stage round in Nov 2025 drew 10 investors.

About Ablative Solutions

Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. The company's platform incorporates a proprietary infusion catheter equipped with guided microneedles that deliver neurolytic agents into the perivascular space surrounding renal arteries, enabling healthcare providers to perform targeted renal denervation procedures with fluoroscopic guidance, minimal invasiveness, and enhanced anatomical precision to address treatment-resistant high blood pressure.

Sector
Healthcare
HQ
Wakefield, MA, United States
Founded
2011
Employees
19
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.